Doki N, Miyawaki S, Tanaka M, Kudo D, Wake A, Oshima K, Fujita H, Uehara T, Hyo R, Mori T, Takahashi S, Okamoto S, Sakamaki H; Kanto Study Group for Cell Therapy: Visceral varicella zoster virus infection after allogeneic stem cell transplantation. Transpl Infect Dis, 15(3): 314-8, 2013.
Fujita H, Asou N, Iwanaga M, Hyo R, Nomura S, Kiyoi H, Okada M, Inaguma Y, Matsuda M, Yamauchi T, Ohtake S, Izumi T, Nakaseko C, Ishigatsubo Y, Shinagawa K, Takeshita A, Miyazaki Y, Ohnishi K, Miyawaki S, Naoe T; Japan Adult Leukemia Study Group: Role of hematopoietic stem cell transplantation for relapsed acute promyelocytic leukemia: a retrospective analysis of JALSG-APL97. Cancer Sci, 104 (10): 1339-45, 2013.
Hirokawa M, Fukuda T, Ohashi K, Hidaka M, Ichinohe T, Iwato K, Kanamori H, Murata M, Sakura T, Imamura M, Adachi S, Suzuki R, Morishima Y, Sakamaki H: Efficacy and long-term outcome of intervention for pure red cell aplasia following allogeneic stem cell transplantation from major ABO-incompatible donors. Biol Blood Marrow Transplant, 19(7): 1026-32, 2013.
Imahashi N, Suzuki R, Fukuda T, Kakihana K, Kanamori H, Eto T, Mori T, Kobayashi N, Iwato K, Sakura T, Ikegame K, Kurokawa M, Kondo T, Iida H, Sakamaki H, Tanaka J, Kawa K, Morishima Y, Atsuta Y, Miyamura K: Allogeneic hematopoietic stem cell transplantation for intermediate cytogenetic risk acute myeloid leukemia in first complete remission. Bone Marrow Transplant, 48(1): 56-62, 2013.
Ishii Y, Yamazaki E, Ishiyama Y, Yamamoto E, Hattori Y, Hagihara M, Tomita N, Ishigatsubo Y: Successful treatment of POEMS syndrome with bortezomib and dexamethasone, combined with radiotherapy, and followed by autologous stem cell transplantation. Int J Hematol, 98(6): 723-8, 2013.
Kako S, Kanamori H, Kobayashi N, Shigematsu A, Nannya Y, Nakamae M, Shigeno K, Suzukawa K, Takeuchi M, Tsuzuki M, Usuki K, Hatanaka K, Ogawa K, Mitani K, Nawa Y, Hatta Y, Mizuno I, Kanda Y: Outcome after first relapse in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia. Br J Haematol, 161(1): 95-103, 2013.
Kako S, Morita S, Sakamaki H, Iida H, Kurokawa M, Miyamura K, Kanamori H, Hara M, Kobayashi N, Morishima Y, Kawa K, Kyo T, Sakura T, Jinnai I, Takeuchi J, Miyazaki Y, Miyawaki S, Ohnishi K, Naoe T, Kanda Y: The role of HLA-matched unrelated transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission. A decision analysis. Bone Marrow Transplant, 48(8): 1077-83, 2013.
Kanamori H, Mizuta S, Kako S, Kato H, Nishiwaki S, Imai K, Shigematsu A, Nakamae H, Tanaka M, Ikegame K, Yujiri T, Fukuda T, Minagawa K, Eto T, Nagamura-Inoue T, Morishima Y, Suzuki R, Sakamaki H, Tanaka J: Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation. Bone Marrow Transplant, 48(12): 1513-8, 2013.
Kurosawa S, Miyawaki S, Yamaguchi T, Kanamori H, Sakura T, Moriuchi Y, Sano F, Kobayashi T, Yasumoto A, Hatanaka K, Yanada M, Nawa Y, Takeuchi J, Nakamura Y, Fujisawa S, Shibayama H, Miura I, Fukuda T: Prognosis of core-binding factor acute myeloid leukemia after first relapse. Haematologica, 98(10):1525-31, 2013.
Matsumoto K, Ito S, Yamamoto W, Ogusa E, Maruta A, Ishigatsubo Y, Kanamori H: Clinical significance of pulmonary function tests in long-term survivors after myeloablative allogeneic stem cell transplantation. Open Journal of Blood Diseases, 3:6-12, 2013.
Mori T, Tanaka M, Kobayashi T, Ohashi K, Fujisawa S, Yokota A, Fujita H, Nakaseko C, Sakura T, Nannya Y, Takahashi S, Kanamori H, Kanda Y, Sakamaki H, Okamoto S: Prospective Multicenter Study of Single-unit Cord Blood Transplantation with Myeloablative Conditioning for Adult Patients with High-risk Hematological Malignancies. Biol Blood Marrow Transplant, 19(3): 486-91, 2013.
Motohashi K, Suzuki T, Kishimoto K, Numata A, Nakajima Y, Tachibana T, Ohshima R, Kuwabara H, Tanaka M, Tomita N, Ishigatsubo Y, Fujisawa S: Successful treatment of a patient with adult T cell leukemia/lymphoma using anti-CC chemokine receptor 4 monoclonal antibody mogamulizumab followed by allogeneic hematopoietic stem cell transplantation. Int J Hematol, 98(2): 258-60, 2013.
Nakajima Y, Kuwabara H, Hattori Y, Ohshima R, Sakai R, Kitagawa M, Tomita N, Ishigatsubo Y, Fujisawa S: Successful treatment of a pregnant woman with Philadelphia chromosome-positive acute lymphoblastic leukemia. Int J Hematol, 97(3): 427-9, 2013.
Ogusa E, Tomita N, Ishii Y, Takasaki H, Hattori Y, Matsumoto C, Ishigatsubo Y: Clinical manifestations of primary pulmonary extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in Japanese population. Hematol Oncol, 31(1):18-21, 2013.
Oshima K, Kanda Y, Nanya Y, Tanaka M, Nakaseko C, Yano S, Fujisawa S, Fujita H, Yokota A, Takahashi S, Kanamori H, Okamoto S; for the Kanto Study Group for Cell Therapy (KSGCT): Allogeneic hematopoietic stem cell transplantation for patients with mildly reduced renal function as defined based on creatinine clearance before transplantation. Ann Hematol, 92(2): 255-60, 2013.
Tachibana T, Nozaki A, Enaka M, Yamamoto E, Kawasaki R, Koharazawa H, Hagihara M, Ishibashi D, Nakajima Y, Kuwabara H, Tomita N, Ishigatsubo Y, Fujisawa S: Drug-induced liver injury after allogeneic bone marrow transplantation. Int J Hematol, 98(4): 499-503, 2013.
Tachibana T, Tanaka M, Yamazaki E, Numata A, Takasaki H, Kuwabara H, Fujimaki K, Sakai R, Fujita H, Fujisawa S, Maruta A, Ishigatsubo Y, Kanamori H: Multicenter validation of scoring system of pre-transplant serum ferritin and disease risk in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplant. Leuk Lymphoma, 54(6): 1318-20, 2013.
Takahashi H, Sakai R, Fujita A, Kuwabara H, Hattori Y, Matsuura S, Ohshima R, Hagihara M, Tomita N, Ishigatsubo Y, Fujisawa S: Concentrated Ascites Reinfusion Therapy for Sinusoidal Obstructive Syndrome After Hematopoietic Stem Cell Transplantation. Artif Organs, 37(10): 932-6, 2013.
Takahashi H, Sakai R, Hattori Y, Ohshima R, Kuwabara H, Hagihara M, Enaka M, Nozawa A, Tomita N, Ishigatsubo Y, Fujisawa S: Successful disease control with L-asparaginase monotherapy for aggressive natural killer cell leukemia with severe hepatic failure. Leuk Lymphoma, 54(3): 662-4, 2013.
Takahashi H, Tomita N, Sakata S, Tsuyama N, Hashimoto C, Ohshima R, Matsuura S, Ogawa K, Yamamoto W, Kameda Y, Enaka M, Inayama Y, Kasahara M, Takekawa Y, Onoda N, Motomura S, Ishigatsubo Y, Takeuchi K: Prognostic significance of programmed cell death-1-positive cells in follicular lymphoma patients may alter in the rituximab era. Eur J Haematol, 90(4): 286-90, 2013.
Takasaki H, Hashimoto C, Fujita A, Matsumoto K, Taguchi J, Kuwabara H, Yamazaki E, Koharazawa H, Fujita H, Fujisawa S, Ishii Y, Yamamoto W, Motomura S, Tomita N, Ishigatsubo Y, Sakai R: Upfront Autologous Stem Cell Transplantation for Untreated High-Risk Diffuse Large B-Cell Lymphoma in Patients Up to 60 Years of Age. Clin Lymphoma Myeloma Leuk, 13(4): 404-9, 2013.
Takasaki H, Ishii Y, Yamamoto W, Tsuchihashi H, Motomura S, Tomita, N, Ishigatsubo Y, Sakai R: Successful treatment with third stem cell transplant from an allogeneic donor for a patient with relapsed diffuse large B-cell lymphoma. Exp Clin Transplant, 11(2):199-202, 2013.
Tanaka J, Morishima Y, Takahashi Y, Yabe T, Oba K, Takahashi S, Taniguchi S, Ogawa H, Onishi Y, Miyamura K, Kanamori H, Aotsuka N, Kato K, Kato S, Atsuta Y, Kanda Y: Effects of KIR-ligand incompatibility on clinical outcomes of umbilical cord blood transplantation without ATG for acute leukemia in complete remission. Blood Cancer J, 29;3:e164. doi: 10.1038/bcj.2013.62, 2013.
Tomita N, Takasaki H, Fujisawa S, Miyashita K, Ogusa E, Kishimoto K, Matsuura S, Sakai R, Koharazawa H, Yamamoto W, Fujimaki K, Fujita H, Ishii Y, Taguchi J, Kuwabara H, Motomura S, Ishigatsubo Y: Standard R-CHOP Therapy in Follicular Lymphoma and Diffuse Large B-Cell Lymphoma. J Clin Exp Hematop, 53(2): 121-5, 2013.
Tomita N, Takasaki H, Miyashita K, Fujisawa S, Ogusa E, Matsuura S, Kishimoto K, Numata A, Fujita A, Ohshima R, Kuwabara H, Hagihara M, Hashimoto C, Takemura S, Koharazawa H, Yamazaki E, Fujimaki K, Taguchi J, Sakai R, Ishigatsubo Y: R-CHOP therapy alone in limited stage diffuse large B-cell lymphoma. Br J Haematol, 161(3): 383-8, 2013.
Washimi K, Yokose T, Amitani Y, Nakamura M, Osanai S, Noda H, Kawachi K, Takasaki H, Akaike M, Kameda Y: Well-differentiated papillary mesothelioma, possibly giving rise to diffuse malignant mesothelioma: a case report. Pathol Int, 63(4):220-5, 2013.
Watanabe R, Tomita N, Kishimoto K, Koyama S, Ogusa E, Ishii Y, Miyashita K, Matsuura S, Fujisawa S, Hattori Y, Takasaki H, Fujita A, Ohshima R, Kuwabara H, Hashimoto C, Fujimaki K, Sakai R, Ishigatsubo Y: Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. Leuk Res, 37(10): 1208-12, 2013.
Watanabe R, Tomita N, Matsumoto C, Hattori Y, Matsuura S, Takasaki H, Hashimoto C, Fujita H, Fujisawa S, Ishigatsubo Y: The 3q27 and 18q21 translocations for follicular lymphoma and diffuse large B-cell lymphoma in the rituximab era. J Clin Exp Hematop, 53(2): 107-14, 2013.
Watanabe T, Hotta C, Koizumi S, Miyashita K, Nakabayashi J, Kurotaki D, Sato GR, Yamamoto M, Nakazawa M, Fujita H, Sakai R, Fujisawa S, Nishiyama A, Ikezawa Z, Aihara M, Ishigatsubo Y, Tamura T: The Transcription Factor IRF8 Counteracts BCR-ABL to Rescue Dendritic Cell Development in Chronic Myelogenous Leukemia. Cancer Res, 73(22): 6642-53, 2013.
Yamamoto E, Tomita N, Sakata S, Tsuyama N, Takeuchi K, Nakajima Y, Miyashita K, Tachibana T, Takasaki H, Tanaka M, Hashimoto C, Koharazawa H, Fujimaki K, Taguchi J, Harano H, Motomura S, Ishigatsubo Y: The MIB-1 labeling index as a prognostic factor for patients with follicular lymphoma treated with rituximab plus CHOP therapy. Cancer Sci, 104(12): 1670-4, 2013.
Yamamoto W, Nakamura N, Tomita N, Ishii Y, Takasaki H, Hashimoto C, Motomura S, Yamazaki E, Ohshima R, Numata A, Ishigatsubo Y, Sakai R: Clinicopathological analysis of mediastinal large B-cell lymphoma and classical Hodgkin lymphoma of the mediastinum. Leuk Lymphoma, 54(5): 967-72, 2013.
Yamamoto W, Ogusa E, Matsumoto K, Maruta A, Ishigatsubo Y, Kanamori H: Recovery of natural killer cells and prognosis after cord blood transplantation. Leuk Res, 37(11): 1522-6, 2013.
Yamamoto W, Tachibana T, Ogusa E, Matsumoto K, Maruta A, Ishigatsubo Y, Kanamori H: Successful azacitidine treatment with increase of regulatory T cells for relapsed acute myeloid leukemia after allogeneic stem cell transplantation. Leuk Lymphoma, 54(9): 2079-80, 2013.
Yanada M, Kurosawa S, Yamaguchi T, Uchida N, Miyawaki S, Kanamori H, Usuki K, Kobayashi T, Watanabe M, Nagafuji K, Yano S, Nawa Y, Tomiyama J, Tashiro H, Nakamura Y, Fujisawa S, Kimura F, Emi N, Miura I, Fukuda T: Effect of related donor availability on outcome of AML in the context of related and unrelated hematopoietic cell transplantation. Bone Marrow Transplant, 48(3): 390-5, 2013.
Yanada M, Tsuzuki M, Fujita H, Fujimaki K, Fujisawa S, Sunami K, Taniwaki M, Ohwada A, Tsuboi K, Maeda A, Takeshita A, Ohtake S, Miyazaki Y, Atsuta Y, Kobayashi Y, Naoe T, Emi N: Phase 2 study of arsenic trioxide followed by autologous hematopoietic cell transplantation for relapsed acute promyelocytic leukemia. Blood, 121(16): 3095-102, 2013.
